je.st
news
Vertex to stop selling hepatitis C drug Incivek, once a blockbuster, in October
2014-08-13 07:02:43| Biotech - Topix.net
Incivek was the first approved drug for Vertex in 2011, but it was quickly overwhelmed by competition from other hepatitis C treatment, including Gilead's Sovaldi.
Tags: in
october
stop
selling
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|